The Company is rapidly progressing the commercialization of its new products and is in discussions for a number of field trials that it expects to commence during the first quarter of 2018, ahead of the commercial launch.
Ann: Quarterly Activities Report and Appendix 4C - December 17, page-10
Add SP3 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.942M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 138880 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 649122 | 4 |
View Market Depth
| Last trade - 16.12pm 29/11/2024 (20 minute delay) ? |
| SP3 (ASX) Chart |
Day chart unavailable
